Accepted at 2:45 a.m. Apr, 29, 2024 by Cameron
Author: balexfree
Co-authors: Cameron
Related Note: 1476919674183
Rationale for change

so we don't answer with just "antimuscarinics"

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::05_Pharm::04_Miscellaneous::01_Drug_names #AK_Step1_v12::#UWorld::COMLEX::23283 #PANCE::PULM::obstructive_pulmonary_diseases #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#Physeo::09_Pharm::16_Autonomic_Pharm::12_Muscarinic_Antagonists #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Bootcamp::Pulmonology::05_Obstructive_Lung_Disease::03_Asthma_Treatments #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::09_Muscarinic_Antagonists #AK_Step1_v12::#UWorld::Step::170 #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::03_Acute_Asthma_Exacerbation_SOAP #PANCE::EOR::PEDS #AK_Step1_v12::#Physeo::09_Pharm::08_Respiratory::07_Alternative_Asthma_Treatment #AK_Step1_v12::#OME_banner #AK_Step2_v12::#SketchyIM::03_Pulmonology::09_Retired_Lessons::02_Obstructive_Pulmonary_Diseases::05_COPD_SOAP_[OLD_VERSION] #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::09_Muscarinic_antagonists::*M3_Antagonists::Inhaled_M3_Antagonists #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::08_Acute_COPD_Exacerbation_SOAP #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::12_Drug_reactions-multiorgan #AK_Step2_v12::#SketchyIM::03_Pulmonology::02_Obstructive_Pulmonary_Diseases::07_COPD_Management #AK_Step1_v12::#Pixorize::03_Pharmacology::20_Respiratory_Pharm::01_Ipratropium_vs_Tiotropium #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::01_Parasympathetic::03_Muscarinic_antagonists